ICH - “Surgery, BP and hemostasis”

      Significant advances have been made for treatment of acute ischemic stroke (AIS) such as thrombolysis and thrombectomy. By contrast, there is yet time before daybreak in the acute management of intracerebral hemorrhage (ICH). In the Japan Stroke Databank, the rate of death or disability in ICH patients has increased, but not in AIS patients for these 10 years (Sato S et al, 2017). Although many therapeutic options, including surgical evacuation, are described for acute ICH patients, nothing has yet been proven in large-scale randomized clinical trials (RCTs).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect